<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Prev Med</journal-id><journal-id journal-id-type="iso-abbrev">Int J Prev Med</journal-id><journal-id journal-id-type="publisher-id">IJPVM</journal-id><journal-title-group><journal-title>International Journal of Preventive Medicine</journal-title></journal-title-group><issn pub-type="ppub">2008-7802</issn><issn pub-type="epub">2008-8213</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23776730</article-id><article-id pub-id-type="pmc">3678224</article-id><article-id pub-id-type="publisher-id">IJPVM-4-234</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>The Effect of Omega-3 Supplements on Antioxidant Capacity in Patients with Type 2 Diabetes</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hajianfar</surname><given-names>Hossein</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Paknahad</surname><given-names>Zamzam</given-names></name><xref ref-type="aff" rid="aff2">1</xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Bahonar</surname><given-names>Ahmad</given-names></name><xref ref-type="aff" rid="aff3">2</xref></contrib></contrib-group><aff id="aff1">Food Security Research Center, Faculty of Nutrition and Food Sciences, Isfahan University of Medical Sciences, Isfahan, Iran</aff><aff id="aff2"><label>1</label>Department of Clinical Nutrition, Faculty of Nutrition and Food Sciences, Isfahan University of Medical Sciences, Isfahan, Iran</aff><aff id="aff3"><label>2</label>Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</aff><author-notes><corresp id="cor1"><bold>Correspondence to:</bold> Dr. Zamzam Paknahad, Department of Clinical Nutrition, Faculty of Nutrition and Food Sciences, Isfahan University of Medical Sciences, Isfahan, Iran. E-mail: <email xlink:href="paknahad@hlth.mui.ac.ir">paknahad@hlth.mui.ac.ir</email></corresp></author-notes><pub-date pub-type="ppub"><month>5</month><year>2013</year></pub-date><volume>4</volume><issue>Suppl 2</issue><issue-title>8th Iranian Neurology Congress</issue-title><fpage>S234</fpage><lpage>S238</lpage><history><date date-type="received"><day>18</day><month>2</month><year>2013</year></date><date date-type="accepted"><day>23</day><month>2</month><year>2013</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; International Journal of Preventive Medicine</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p>Diabetes is one of the most common chronic diseases in which antioxidant capacity changes. Omega-3 fatty acids have extensive biological effects including their advantage on lipoprotein metabolism, platelet function, cytokine production, clotting, fibrinolysis, and inflammatory factors. This study aimed to investigate the effect of omega-3 fatty acid supplements on antioxidant capacity in patients with type 2 diabetes.</p></sec><sec id="st2"><title>Methods:</title><p>This clinical trial enrolled 71 women with type 2 diabetes in two case (treated with omega-3 capsules) and control (treated with placebo) groups. In the first stage, participants filled out a demographics questionnaire including age, height, weight, waist circumference, and hip circumference.Their blood sample was taken to evaluate glycosylated hemoglobin and antioxidant capacity. Then the case group received intervention for 8 weeks and weight, waist circumference, and hip circumference were measured and a blood sample was taken again. The data were analyzed using SPSS 18 software.</p></sec><sec id="st3"><title>Results:</title><p>The mean difference of antioxidant capacity before and after intervention was significant (<italic>P</italic> &#x0003c; 0.001). Antioxidant capacity increased in the case group and reduced in the control group.</p></sec><sec id="st4"><title>Conclusions:</title><p>With regard to the results of the present study, patients with type 2 diabetes increase their antioxidant capacity, enhance their antioxidant defense system, and probably prevent diabetes complications and related disease progress by taking omega-3 supplements.</p></sec></abstract><kwd-group><kwd>Antioxidant capacity</kwd><kwd>omega-3 supplement</kwd><kwd>type 2 diabetes</kwd></kwd-group></article-meta></front><body><sec id="sec1-1"><title>INTRODUCTION</title><p>Diabetes is a relatively prevalent disease that occurs as a result of lack or dysfunction of insulin.[<xref ref-type="bibr" rid="ref1">1</xref>] Approximately 6% American have different levels of glucose metabolism disorder, which indicate diabetes or the tendency to have diabetes.[<xref ref-type="bibr" rid="ref2">2</xref>] According to WHO, the prevalence of type 2 diabetes was estimated to be 5.5, 5.7, and 6.8% in 1995, 2000, and 2005, respectively.[<xref ref-type="bibr" rid="ref3">3</xref>]</p><p>Stephens <italic>et al</italic>. studied the biological relationship and measured plasma markers of oxidative stress in diabetic and cardiovascular patients and found a close relationship between diabetes mellitus and increased oxidative stress.[<xref ref-type="bibr" rid="ref4">4</xref>]</p><p>Adiposity and a longer duration of obesity are important risks factors for type 2 diabetes, and even little weight losses are associated with a maodulataion of hyperglycemia in persons with prediabetes.[<xref ref-type="bibr" rid="ref5">5</xref>]</p><p>Review studies have shown that the level of free radicals increases and the level of antioxidants decreases during diabetes.[<xref ref-type="bibr" rid="ref6">6</xref>] Linoleic acid (omega-6) and Linolenic acid (omega-3) have important roles in body functions, but they cannot be produced in the absence or lack of an enzyme.[<xref ref-type="bibr" rid="ref7">7</xref>] Mori <italic>et al</italic>.[<xref ref-type="bibr" rid="ref7">7</xref>] studied the effect of EPA, DHA, and olive oil on oxidative stress and biochemical parameters of patients with type 2 diabetes and found that EPA and DHA reduce oxidative stress without changing inflammatory markers in patients with type 2 diabetes.[<xref ref-type="bibr" rid="ref7">7</xref>] Thorsdottir <italic>et al</italic>.,[<xref ref-type="bibr" rid="ref8">8</xref>] from Iceland concluded that omega-3 fatty acids in milk reduces type 2 diabetes in men.[<xref ref-type="bibr" rid="ref8">8</xref>] Lean <italic>et al</italic>.[<xref ref-type="bibr" rid="ref9">9</xref>] concluded that omega-3 fatty acids significantly reduce serum lipids and control serum sugar in patients with type 2 diabetes.[<xref ref-type="bibr" rid="ref9">9</xref>] With regard to high prevalence and irreparable complications of diabetes, there is probable role of free radicals in the developmentand progress of the disease as well as the fact that omega-3 fatty acids have extensive biological effects on lipoprotein metabolism, platelet function, cytokine production, clotting, fibrinolysis, and inflammatory factors.[<xref ref-type="bibr" rid="ref7">7</xref>] Hajianfar <italic>et al</italic>. found that omega-3 reduced weight in the case group that used omega-3 vs. control group.[<xref ref-type="bibr" rid="ref10">10</xref>] This study aimed to investigate the effect of omega-3 fatty acid supplement on antioxidant capacity of patients with type 2 diabetes.</p></sec><sec sec-type="methods" id="sec1-2"><title>METHODS</title><p>This study was a double-blind randomized placebo controlled clinical trial. The study population consisted of 45-65 year-old women with type 2 diabetes admitted to Shariaty Clinic in Isfahan. Considering the extra 15%, sample size in each group was estimated 39 people.</p><p>Thirty-seven volunteers were recruited in the case group and 34 entered the placebo group after signing the informed written consent form. Inclusion criteria were type 2 diabetes for at least 5 years, no insulin shot, no secondary complications of diabetes such as ophthalmologic complications, renal complications, amputation, renal diseases, blindness, cardiovascular diseases, and no high CRP.</p><p>At the beginning of study, demoghraphic characteristics were gathered by questionnaire. Blood sampling was done after 10-12 hrs fasting. Biochemical indices including serum antioxidant capacity and HbA1c were measured. Then, the subjects received supplement or placebo according to the groups for 8 weeks. At the end of study, we measured anthropometric and biochemical indices again.</p><sec id="sec2-1"><title>Anthropometrical measurements</title><p>A digital scale (seca) was used to measure weight with an accuracy of +100g. Subjects were weighed without shoes and light clothing. Height was measured without shoes to the nearest 0.5 cm with the use of a commercial stadiometer with the shoulders in relaxed position and arms hanging freely. Body mass index (BMI) was calculated by dividing weight (kg) by height (m<sup>2</sup>).</p><p>Both the lab technician and the patients were unaware of the intervention. Data were analyzed using SPSS 18 software, and tables and charts were drawn. Fisher's exact test was used for qualitative information, <italic>t</italic> test was used for quantitative test, Chi square test was used for weight changes, and Pearson's correlation test was used for data correlation. Changes between two groups were compared using independent <italic>t</italic> test. Pearson's regression was used to find relationship between variables.</p></sec><sec id="sec2-2"><title>Findings</title><p>The results showed that the omega-3 group and placebo group were not significantly different in terms of age, education, and occupation. Furthermore, other variables like comorbid diseases, medication, and diet were not significantly different between the two groups. Therefore, they cannot be considered confounding factor is this study.</p><p>Mean age of patients was 53.6 &#x000b1; 4.3 and 53.9 &#x000b1; 5.4 in the case and control groups, respectively. According to <italic>t</italic> test, no significant difference was found between the two groups in this regard (<italic>P</italic> = 0.79). Mean of serum age, BMI, weight, HbA1c concentration and antioxidant capacity and comparison of the changes before and after intervention at two groups is showen in Table <xref ref-type="table" rid="T1">1</xref> and <xref ref-type="table" rid="T2">2</xref>.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Mean of age, BMI, weight, concentration of serum HbA1c and antioxidant capacity before and after intervention at two groups</p></caption><graphic xlink:href="IJPVM-4-234-g001"/></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Comparison of changes in anthropometric and biochemical indices between two groups (&#x003c9;3 and placebo)</p></caption><graphic xlink:href="IJPVM-4-234-g002"/></table-wrap></sec></sec><sec sec-type="discussion" id="sec1-3"><title>DISCUSSION</title><p>The main objective of this study was to determine the effect of omega-3 supplement on antioxidant capacity of patients with diabetes type 2. The results show that taking omega-3 supplement increases antioxidant capacity and reduces HbA1c in patients with type 2 diabetes. This finding shows the role of omega-3 supplement in controlling HbA1c, which is a criterion to evaluate the control level of serum glucose in diabetes. This finding is in agreement with that of other studies.[<xref ref-type="bibr" rid="ref11">11</xref>] Omega-3 consumption reduced HbA1c in diabetic patients,[<xref ref-type="bibr" rid="ref12">12</xref><xref ref-type="bibr" rid="ref13">13</xref>] but this change was not significant in Kesuvalu's study.[<xref ref-type="bibr" rid="ref14">14</xref>] Several studies confirm the results of this study about increase in antioxidant capacity after taking omega-3 supplement. Suresh <italic>et al</italic>.,[<xref ref-type="bibr" rid="ref15">15</xref>] concluded that omega-3 can improve oxidative stress in diabetes, which corresponds with the result of the present study. Mori <italic>et al</italic>.,[<xref ref-type="bibr" rid="ref7">7</xref>] found that EPA and DHA reduced oxidative stress in type 2 diabetes. This finding is against that of some studies by Fokine <italic>et al</italic>.,[<xref ref-type="bibr" rid="ref16">16</xref>] Samaoui <italic>et al</italic>.,[<xref ref-type="bibr" rid="ref17">17</xref>] studied the relationship between fat in diet and antioxidants in diabetic patients and found that antioxidant capacity in diabetic patients who did not control diabetes well was reduced. Blaszzak <italic>et al</italic>.[<xref ref-type="bibr" rid="ref18">18</xref>] reported an increase in antioxidant capacity of diabetic patients, which is in line with our findings. Pasaogala <italic>et al</italic>., (2004) found that the level of oxidative stress in patients with type 2 diabetes was higher than that in the control group. The amount of free radicals in patients with type 2 diabetes increases and antioxidant resistance reduces, therefore oxidative stress increases in such people.[<xref ref-type="bibr" rid="ref19">19</xref>] Kasuvalu showed that omega-3 reduced free radicals and increased antioxidant enzymes in this group,[<xref ref-type="bibr" rid="ref14">14</xref>] which is in line with our finding. Antioxidants reduce in these patients because increased free radicals cause different diseases including diabetes, and weaken antioxidant system. Tayyebi-Khosroshahi[<xref ref-type="bibr" rid="ref20">20</xref>] concluded that omega-3 in hemodialysis patients increased antioxidant factors like glutathione peroxide and superoxide mutase Hiratsuka[<xref ref-type="bibr" rid="ref21">21</xref>] found that DHA rich diet has antioxidant activity in rat's brain. Omega-3 reduces triglyceride and oxidative stress.[<xref ref-type="bibr" rid="ref22">22</xref>]</p><p>This study resulted in the following, aiming to investigate the effect of omega-3 supplement on antioxidant capacity of patients with type 2 diabetes. HbA1c and antioxidant capacity in these people were significant, indicating that the intervention was useful and increased antioxidant capacity in these people. Considering the probable role of antioxidant system in causing type 2 diabetes, we can prevent type 2 diabetes in healthy people and reduce diabetes complications and its progress by boosting their antioxidant defense system.</p></sec><sec sec-type="conclusions" id="sec1-4"><title>CONCLUSIONS</title><p>Some studies found a significant relationship between the level of serum visfatin and BMI of the participants.[<xref ref-type="bibr" rid="ref23">23</xref>&#x02013;<xref ref-type="bibr" rid="ref26">26</xref>] This finding is against the findings of Pagano <italic>et al</italic>.,[<xref ref-type="bibr" rid="ref27">27</xref>] on fat non-diabetic patients and that of Samara <italic>et al</italic>.,[<xref ref-type="bibr" rid="ref28">28</xref>] on non-diabetic people with different weights; they found an inverse relationship between BMI and Visfatin. Furthermore, Chen <italic>et al</italic>.,[<xref ref-type="bibr" rid="ref29">29</xref>] found a significant relationship between serum visfatin and BMI in patients with type 2 diabetes.</p><sec id="sec2-3"><title>Recommendation</title><p>Since weakening of antioxidant system can cause diabetes and because findings of the present study showed that omega-3 supplement can increase antioxidant capacity, consumption of omega-3 supplement is recommended as primary prevention and secondary prevention of diabetes complications.</p></sec></sec></body><back><ack><title>ACKNOWLEDGMENT</title><p>This study was conducted by a grant from school of public health, Tehran University of Medical Sciences. The authors have no conflict of interest. All finance payment by first author.</p></ack><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mokini</surname><given-names>Z</given-names></name><name><surname>Marcovecchio</surname><given-names>M</given-names></name><name><surname>Chiarelli</surname><given-names>F</given-names></name></person-group><article-title>Moleculare pathology of oxidative stress in diabetic angiopathy: Role of mitochondrial and cellular pathway: A review</article-title><source>Diabetes Res Clin Pract</source><year>2009</year><volume>75</volume><fpage>435</fpage><lpage>45</lpage></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afzali</surname><given-names>Z</given-names></name><name><surname>Pilevariyan</surname><given-names>A</given-names></name></person-group><article-title>Maleki Compare stress oxidative in patient diabetics type 2 with healthy</article-title><source>J Mens health</source><year>2008</year><volume>2,4</volume><fpage>129</fpage><lpage>34</lpage></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>H</given-names></name><name><surname>Aubert</surname><given-names>RE</given-names></name><name><surname>Herman</surname><given-names>WH</given-names></name></person-group><article-title>Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections</article-title><source>Diabetes Care</source><year>1998</year><volume>21</volume><fpage>1414</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">9727886</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephens</surname><given-names>J</given-names></name><name><surname>Khanolkar</surname><given-names>M</given-names></name><name><surname>Bain</surname><given-names>S</given-names></name></person-group><article-title>The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease</article-title><source>Atherosclerosis</source><year>2009</year><volume>20</volume><fpage>321</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18640680</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Franz</surname><given-names>MJ</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Mahan</surname><given-names>K</given-names></name><name><surname>Escott</surname><given-names>Stump S</given-names></name><name><surname>Raymond</surname><given-names>J</given-names></name></person-group><article-title>Medical nutrition therapy for diabetes mellitus and hypoglycemia of nondiabetic origion</article-title><source>Krause's Food and Nutrition Care Process</source><edition>13th ed</edition><publisher-loc>USA</publisher-loc><publisher-name>Saunders Elsevier</publisher-name><fpage>678</fpage><lpage>9</lpage></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maritim</surname><given-names>AC</given-names></name><name><surname>Sanders</surname><given-names>RA</given-names></name><name><surname>Watkins</surname><given-names>JB</given-names><suffix>3rd</suffix></name></person-group><article-title>Diabetes, oxidative stress, antioxidants: A review</article-title><source>J Biochem Mol Toxicol</source><year>2003</year><volume>17</volume><fpage>24</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">12616644</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>T</given-names></name><name><surname>Woodman</surname><given-names>R</given-names></name><name><surname>Burke</surname><given-names>V</given-names></name><name><surname>Puddy</surname><given-names>I</given-names></name><name><surname>Croft</surname><given-names>K</given-names></name><name><surname>Beilin</surname><given-names>L</given-names></name></person-group><article-title>Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated hypertensive type 2 diabetic subjects</article-title><source>Free Radic Biol Med</source><year>2003</year><volume>35</volume><fpage>772</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">14583341</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorsdottir</surname><given-names>I</given-names></name><name><surname>Hill</surname><given-names>J</given-names></name><name><surname>Ramel</surname><given-names>A</given-names></name></person-group><article-title>Omega 3 fatty acid supply from milk associates with lower type 2 diabetes in men and coronary heart disease in women</article-title><source>Prev Med</source><year>2004</year><volume>39</volume><fpage>630</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">15313105</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacLean</surname><given-names>CH</given-names></name><name><surname>Mojica</surname><given-names>WA</given-names></name><name><surname>Morton</surname><given-names>SC</given-names></name><name><surname>Pencharz</surname><given-names>J</given-names></name><name><surname>Hasenfeld Garland</surname><given-names>R</given-names></name><etal/></person-group><article-title>Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis</article-title><source>Evid Rep Technol Assess (Summ)</source><year>2004</year><volume>89</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">15133890</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hajianfar</surname><given-names>H</given-names></name><name><surname>Hosseinzadeh</surname><given-names>MJ</given-names></name><name><surname>Bahonar</surname><given-names>A</given-names></name><name><surname>Mohammad</surname><given-names>K</given-names></name><name><surname>Askari</surname><given-names>GR</given-names></name><name><surname>Entezari</surname><given-names>MH</given-names></name><etal/></person-group><article-title>The effect of omega-3 on the serum visfatin concentration on the patients with type II diabetes versus placebo</article-title><source>J Res Med Sci</source><year>2011</year><volume>16</volume><fpage>490</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">22091264</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doughman</surname><given-names>SD</given-names></name><name><surname>Krupanidhi</surname><given-names>S</given-names></name><name><surname>Sanjeevi</surname><given-names>CB</given-names></name></person-group><article-title>Omega-3 fatty acid for nutrition and medicine: Considering microalgae oil as a vegetarian source of EPA and DHA</article-title><source>Curr Diabetes Rev</source><year>2007</year><volume>3</volume><fpage>198</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">18220672</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolfarm</surname><given-names>S</given-names></name><name><surname>Raederstorff</surname><given-names>D</given-names></name><name><surname>Preller</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Teixeira</surname><given-names>SR</given-names></name><name><surname>Riegger</surname><given-names>C</given-names></name><etal/></person-group><article-title>Pigallocatechingallate supplementation alleviates diabetes in rodent</article-title><source>J Nutr</source><year>2006</year><volume>136</volume><fpage>2512</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16988119</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McManus</surname><given-names>RM</given-names></name><name><surname>Jumpson</surname><given-names>J</given-names></name><name><surname>Finegood</surname><given-names>DT</given-names></name><name><surname>Clandinin</surname><given-names>MT</given-names></name><name><surname>Tyan</surname><given-names>EA</given-names></name></person-group><article-title>A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well controlled type II diabetes</article-title><source>Diabetes Care</source><year>1996</year><volume>19</volume><fpage>463</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">8732710</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kesavulu</surname><given-names>MM</given-names></name><name><surname>Kameswararao</surname><given-names>B</given-names></name><name><surname>Apparao</surname><given-names>Ch</given-names></name><name><surname>Kumar</surname><given-names>EG</given-names></name><name><surname>Harinarayan</surname><given-names>CV</given-names></name></person-group><article-title>Effect of omega3 fatty acids on lipid peroxidation and antioxidant enzyme status in type 2 diabetes patients</article-title><source>Diabetes Metab</source><year>2002</year><volume>28</volume><fpage>20</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11938024</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suresh</surname><given-names>Y</given-names></name><name><surname>Das</surname><given-names>U</given-names></name></person-group><article-title>Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus</article-title><source>Nutrition</source><year>2003</year><volume>19</volume><fpage>213</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">12620523</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukino</surname><given-names>Y</given-names></name><name><surname>Shimbo</surname><given-names>M</given-names></name><name><surname>Aoki</surname><given-names>N</given-names></name><name><surname>Okubo</surname><given-names>T</given-names></name><name><surname>Iso</surname><given-names>H</given-names></name></person-group><article-title>Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers</article-title><source>J Nutr Sci Vitaminol (Tokyo)</source><year>2005</year><volume>51</volume><fpage>335</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">16392704</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smaoui</surname><given-names>M</given-names></name><name><surname>Koubaa</surname><given-names>N</given-names></name><name><surname>Hammami</surname><given-names>S</given-names></name><name><surname>Abid</surname><given-names>N</given-names></name><name><surname>Feki</surname><given-names>M</given-names></name><name><surname>Chaaba</surname><given-names>R</given-names></name><etal/></person-group><article-title>Association between dietary fat and antioxidant status of Tunisian type 2 diabetic patients</article-title><source>Prostaglandins Leukot Essent Fatty Acids</source><year>2006</year><volume>5</volume><fpage>323</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16584877</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blaszzak</surname><given-names>R</given-names></name><name><surname>Kujawski</surname><given-names>K</given-names></name><name><surname>Kedziora-Kornatowska</surname><given-names>K</given-names></name><name><surname>Kornatowski</surname><given-names>T</given-names></name><name><surname>Kedziora</surname><given-names>J</given-names></name><name><surname>Szadurski</surname><given-names>L</given-names></name><etal/></person-group><article-title>The total antioxidant capacity and low-molecular antioxidants concentration in plasma in diabetes type 2 patient in different stage of metabolic compensation and concomitant diabetic nephropathy</article-title><source>Pol Merkur Lekarski</source><year>2005</year><volume>18</volume><fpage>29</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">15859542</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasaoglu</surname><given-names>H</given-names></name><name><surname>Sancak</surname><given-names>B</given-names></name><name><surname>Bukan</surname><given-names>N</given-names></name></person-group><article-title>Lipid peroxidation and resistance to oxidation in patients with type 2 diabetes mellitus</article-title><source>Tohoku J Exp Med</source><year>2004</year><volume>203</volume><fpage>211</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15240931</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tayyebi-Khosroshahi</surname><given-names>H</given-names></name><name><surname>Houshyar</surname><given-names>J</given-names></name><name><surname>Tabrizi</surname><given-names>A</given-names></name><name><surname>Vatankhah</surname><given-names>AM</given-names></name><name><surname>Razzagi Zonouz</surname><given-names>N</given-names></name><name><surname>Dehghan-Hesari</surname><given-names>R</given-names></name></person-group><article-title>Effect of omega-3 fatty acid on oxidative stress in patients on hemodialysis</article-title><source>Iran J Kidney Dis</source><year>2010</year><volume>4</volume><fpage>322</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">20852375</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiratsuka</surname><given-names>S</given-names></name><name><surname>Ishihara</surname><given-names>K</given-names></name><name><surname>Kitagawa</surname><given-names>T</given-names></name><name><surname>Wada</surname><given-names>S</given-names></name><name><surname>Yokogoshi</surname><given-names>H</given-names></name></person-group><article-title>Effect of dietary docosahexaenoic acid connecting phospholipids on the lipid peroxidation of the brain in mice</article-title><source>J Nutr Sci Vitaminol (Tokyo)</source><year>2008</year><volume>54</volume><fpage>501</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">19155590</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zak</surname><given-names>A</given-names></name><name><surname>Zeman</surname><given-names>M</given-names></name><name><surname>Turzicka</surname><given-names>E</given-names></name><name><surname>Stolba</surname><given-names>P</given-names></name></person-group><article-title>The effect of fish oil on metabolic parameters in patient with type 2 diabetes associated with dyslipidemia</article-title><source>Cas Lak Cesk</source><year>1996</year><volume>135</volume><fpage>354</fpage><lpage>9</lpage></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haider</surname><given-names>DG</given-names></name><name><surname>Schindler</surname><given-names>K</given-names></name><name><surname>Schaller</surname><given-names>G</given-names></name><name><surname>Prager</surname><given-names>G</given-names></name><name><surname>Wolzt</surname><given-names>M</given-names></name><name><surname>Ludvik</surname><given-names>B</given-names></name></person-group><article-title>Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding</article-title><source>J Clin Endocrinol Metab</source><year>2006</year><volume>91</volume><fpage>1578</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">16449335</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukuhara</surname><given-names>A</given-names></name><name><surname>Matsuda</surname><given-names>M</given-names></name><name><surname>Nishizawa</surname><given-names>M</given-names></name><name><surname>Segawa</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>M</given-names></name><name><surname>Kishimoto</surname><given-names>K</given-names></name><etal/></person-group><article-title>Visfatin: A protein secreted by visceral fat that mimics the effects of insulin</article-title><source>Science</source><year>2005</year><volume>307</volume><fpage>426</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">15604363</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bemdt</surname><given-names>J</given-names></name><name><surname>Kloting</surname><given-names>N</given-names></name><name><surname>Kralisch</surname><given-names>S</given-names></name><name><surname>Kovacs</surname><given-names>P</given-names></name><name><surname>Fasshauer</surname><given-names>M</given-names></name><name><surname>Schon</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Plasma visfatin concentrations and fat depot-specific mRNA expression in humans</article-title><source>Diabetes</source><year>2005</year><volume>54</volume><fpage>2911</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16186392</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandeep</surname><given-names>S</given-names></name><name><surname>Velmurugan</surname><given-names>K</given-names></name><name><surname>Deepa</surname><given-names>R</given-names></name><name><surname>Mohan</surname><given-names>V</given-names></name></person-group><article-title>Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians</article-title><source>Metabolism</source><year>2007</year><volume>56</volume><fpage>565</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">17379018</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagano</surname><given-names>C</given-names></name><name><surname>Pilon</surname><given-names>C</given-names></name><name><surname>Olivieri</surname><given-names>M</given-names></name><name><surname>Mason</surname><given-names>P</given-names></name><name><surname>Fabris</surname><given-names>R</given-names></name><name><surname>Serra</surname><given-names>R</given-names></name><etal/></person-group><article-title>Reduced plasma visfatin/pre B-cell colony enhancing factor in obesity is not related to insulin resistance in humans</article-title><source>J Clin Endocrinol Metab</source><year>2006</year><volume>91</volume><fpage>3165</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">16720654</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samara</surname><given-names>A</given-names></name><name><surname>Ptister</surname><given-names>M</given-names></name><name><surname>Marie</surname><given-names>B</given-names></name><name><surname>Visvikis-Siest</surname><given-names>S</given-names></name></person-group><article-title>Visfatin, low-grade inflammation and body mass index (BMI)</article-title><source>Clin Endocrinol (Oxf)</source><year>2008</year><volume>69</volume><fpage>568</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">18248642</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>MP</given-names></name><name><surname>Chung</surname><given-names>FM</given-names></name><name><surname>Chang</surname><given-names>DM</given-names></name><name><surname>Tsai</surname><given-names>JC</given-names></name><name><surname>Huang</surname><given-names>HF</given-names></name><name><surname>Shin</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus</article-title><source>J Clin Endocrinol Metab</source><year>2006</year><volume>91</volume><fpage>295</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16234302</pub-id></element-citation></ref></ref-list></back></article>